{
"Overview_Quick_Start_Guide.csv": "2970",
"Consensus_Committee_Analytic_Dataset.csv": "3362",
"PPMI_Analytic_Dataset_Guide.csv": "3363",
"PPMI_Data_User_Guide.csv": "3492",
"Code_List.csv": "2822",
"Code_List_-__Annotated_.csv": "2823",
"Data_Dictionary.csv": "2820",
"Data_Dictionary_-__Annotated_.csv": "2821",
"Deprecated_Variables.csv": "2824",
"PPMI_Data_Access_Guidelines.csv": "3438",
"Method_for_Calculating_Levodopa_Equivalent_Dose_in_PPMI_Data.csv": "3519",
"Data_Download_Content_Overview.csv": "62",
"Study_CRFs_and_Assessments.csv": "3437",
"Family_History.csv": "2635",
"Consensus_APOE_SNPs_and_GBA_and_LRRK2_Coding_Variant_Summary.csv": "2967",
"Consensus_APOE_SNPs_and_GBA_and_LRRK2_Coding_Variant_Summary_Methods.csv": "3084",
"Participant_Genetic_Status_for_Selected_PD-Associated_Variants.csv": "1707",
"Participant_Genetic_Status_for_Selected_PD-Associated_Variants_Methods.csv": "1689",
"Participant_Status.csv": "2543",
"Age_at_visit.csv": "2834",
"Demographics.csv": "2544",
"Socio-Economics.csv": "2576",
"Subject_Cohort_History.csv": "2545",
"iPSC_Catalog_Guide.csv": "3120",
"iPSC_Catalog_Metadata.csv": "3105",
"IUSM_Assay_Development_Specimen_Catalog.csv": "1342",
"IUSM_Biospecimen_Inventory_Catalog.csv": "1150",
"IUSM_Cell_Line_Catalog.csv": "1370",
"Biospecimen_Analysis_Results_Overview.csv": "1621",
"Current_Biospecimen_Analysis_Results.csv": "2814",
"Deprecated_Biospecimen_Analysis_Results.csv": "2817",
"Pilot_Biospecimen_Analysis_Results.csv": "2816",
"Project_181_Adaptive_Immune_Markers_for_Predicting_Cognitive_Decline_in_PD.csv": "2835",
"104_Project_Methods__ApoE_Genotyping_in_DNA.csv": "364",
"105_Project_Methods__Evaluation_of_PD-linked_Transcripts_in_PPMI.csv": "777",
"106_Project_Methods__Selected_SNPs.csv": "768",
"108_Project_Methods__Immunochip_Genotyping_on_DNA_Samples.csv": "721",
"112_Project_Methods__ApoeA1_and_EGF.csv": "774",
"113_Project_Methods__IGF-1_and_DAT_imaging_as_biomarkers_of_early_cognitive_impairment_in_PD.csv": "916",
"114_Project_Methods___Whole_Blood_RNA_Biomarkers_of_PD.csv": "953",
"118_Project_Methods__PD_associated_genotypes.csv": "2755",
"119_Project_Methods__Validation_of_a_blood_based_gene_expression_assay.csv": "1345",
"122_Project_Methods__Quantification_of_catecholamine_metabolites\u00a0in_CSF.csv": "1627",
"123_Project_Methods__Blood_Biomarker_for_Parkinson_s_Disease.csv": "1523",
"124_Project_Methods__Total_alpha-synuclein_measurements_in_longitudinal_CSF_samples.csv": "1517",
"125_Project_Methods_A-beta__tau__and_p-tau_measurements_in_longitudinal_CSF.csv": "1588",
"126_Project_Methods__GBA_Sequencing.csv": "1994",
"127_Project_Methods__Profiling_PINK1-Parkin_functionality_in_patient_fibroblasts_using_chemical_probes.csv": "1596",
"129_Project_Methods__Miro_Biomarker_for_Parkinson_s_Disease.csv": "1561",
"130_Project_Methods__Role_of_cell-free_mitochondrial_DNA_in_neurodegenerative_disease.csv": "1465",
"132_Project_Methods__GBA-Related_Biomarkers_in_PD__GCase_Activity.csv": "1708",
"134_Project_Methods__2016_CSF_Hb_measurements.csv": "1525",
"135_Project_Methods__GBA-Related_Biomarkers_in_PD__Lipid_Substrates.csv": "2122",
"136_Project_Methods_Altered_calcium_activity_patterns_in_developing_dopaminergic_neurons_from_PD_patients.csv": "3080",
"137_Project_Methods__Urate_and_Nrf2_pathway_effects_on_mutant_LRRK_toxicity_in_iPSC-derived_DA_neurons.csv": "2344",
"143_Project_Methods__Investigating_Miro1_as_a_molecular_marker_for_PD_and_its_risk.csv": "2799",
"144_Project_Methods__Investigation_of_neurofilament_light_chain_in_serum_from_the_PPMI_cohorts_as_a_progression_marker_for_PD.csv": "1982",
"145_Project_Methods__Do_urinary_BMP_levels_change_with_disease_progression.csv": "1997",
"151_Project_Annotations__Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF.csv": "2542",
"152_Project_Methods__Roche_NeuroTool_Kit.csv": "2151",
"153_Project_Methods__Mitochondrial\u00a0transporter\u00a0defects\u00a0as\u00a0a\u00a0potential\u00a0biomarker\u00a0in\u00a0patient-derived\u00a0cells.csv": "2330",
"155_Project_Methods__a-syn_oligomers_in_CSF_using_PMCA_Phase_2.csv": "3175",
"158_Project_Methods__Effect_of_small_molecules_to_rescue_lysosomal_and_GBA-1_deficiencies_in_GBA-PD.csv": "2064",
"159_Project_Methods__CSF_A-beta__tau__and_p-tau_analysis.csv": "2829",
"160_Project_Methods__Association_of_repetitive_elements_with_PD_risk___progression.csv": "2345",
"165_Project_Methods__Is_poly__ADP-ribose__in_the_CSF_a_biomarker_for_PD_diagnosis_or_progression_.csv": "3022",
"172_Project_Methods__aSyn_RT-QuIC_rapid_and_ultra-sensitive_quantitation_of_disease-associated_a-synuclein_seeds_in_CSF.csv": "2546",
"173_Project_Methods__Evaluation_of_seeding-competent_alpha-syn_in_the_CSF_as_a_biomarker_for_prodromal_PD.csv": "2439",
"180_Project_Methods__Metabolomic_Analysis_of_Penetrance__Prognosis_and_Tracking_Biomarkers_of_LRRK2_PD.csv": "3160",
"181_Project_Methods__Adaptive_Immune_Markers_for_Predicting_Cognitive_Decline.csv": "2836",
"182_Project_Methods__Validation_of_plasmalogen_augmentation_as_a_viable_drug_target_in_Parkinson_s_Disease.csv": "2277",
"190_Project_Methods__Targeted___untargeted_MS-based_proteomics_of_urine_in_PD.csv": "3076",
"195_Project_Methods__Detection_of_GBA_mutations_by_combination_of_Illumina_and_Nanopore_sequencing.csv": "3106",
"200_Project_Methods__Pilot_and_Large-Scale_Study_for_ASYN_in_PPMI_CSF__STAGE_I_.csv": "2553",
"207_Project_Methods__Analysis_of_Soluble_alpha-Synuclein_Aggregates_in_CSF_by_Semi-Quantitative_Seed_Amplification_Assay__SAA_.csv": "3194",
"209_Project_Methods__Identification_of_NLRP3_inflammasome-related_biomarkers_in_PPMI_CSF.csv": "3244",
"215_Project_Methods__GBA_activity___PGRN_levels_in_leftover_PPMI_biosamples.csv": "3156",
"219_Project_Methods__Evaluation_of_TMPRSS5__Spinesin__in_the_CSF_as_a_potential_biomarker_for_early_Parkinson_s_disease_diagnosis_and_progression.csv": "3085",
"221_Project_Methods__CSF_total_LRRK2_measurements_as_a_Biomarker_in_genetic_PD.csv": "3279",
"237_Project_Methods__Analysis_of_CSF_Samples_Using_Amprion_s_alpha-synuclein-SAA_Test.csv": "3325",
"245_Project_Methods__Adaptive_immunity_in_the_etiology_and_progression_of_Parkinson_s_disease.csv": "3428",
"Reference_Pool_Methods__CSF__plasma__RNA__serum_.csv": "1468",
"Blood_Chemistry___Hematology.csv": "2502",
"Clinical_Labs.csv": "2589",
"Genetic_Testing_Results__Merge_.csv": "2965",
"Laboratory_Procedures_with_Elapsed_Times.csv": "2818",
"Lumbar_Puncture.csv": "2742",
"Research_Biospecimens.csv": "2547",
"Skin_Biopsy.csv": "2695",
"Project_180_Metabolomic_Analysis_of_Penetrance__Prognosis_and_Tracking_Biomarkers_of_LRRK2_PD_1_of_5.csv": "3067",
"Project_180_Metabolomic_Analysis_of_Penetrance__Prognosis_and_Tracking_Biomarkers_of_LRRK2_PD_2_of_5.csv": "3068",
"Project_180_Metabolomic_Analysis_of_Penetrance__Prognosis_and_Tracking_Biomarkers_of_LRRK2_PD_3_of_5.csv": "3069",
"Project_180_Metabolomic_Analysis_of_Penetrance__Prognosis_and_Tracking_Biomarkers_of_LRRK2_PD_4_of_5.csv": "3070",
"Project_180_Metabolomic_Analysis_of_Penetrance__Prognosis_and_Tracking_Biomarkers_of_LRRK2_PD_5_of_5.csv": "3157",
"Neuropathology_Results.csv": "3277",
"214_Project_Methods__O-Link_Measurements_in_Prodromal_PPMI.csv": "3243",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_1_of_6.csv": "2430",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_1_of_7_Batch_Corrected_.csv": "3130",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_2_of_6.csv": "2431",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_2_of_7_Batch_Corrected_.csv": "3131",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_3_of_6.csv": "2432",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_3_of_7_Batch_Corrected_.csv": "3132",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_4_of_6.csv": "2433",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_4_of_7_Batch_Corrected_.csv": "3133",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_5_of_6.csv": "2434",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_5_of_7_Batch_Corrected_.csv": "3134",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_6_of_6.csv": "2435",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_6_of_7_Batch_Corrected_.csv": "3135",
"Project_151_Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF_7_of_7_Batch_Corrected_.csv": "3136",
"Project_190_Targeted___untargeted_MS-based_proteomics_of_urine_in_PD_1_of_5.csv": "3071",
"Project_190_Targeted___untargeted_MS-based_proteomics_of_urine_in_PD_2_of_5.csv": "3072",
"Project_190_Targeted___untargeted_MS-based_proteomics_of_urine_in_PD_3_of_5.csv": "3073",
"Project_190_Targeted___untargeted_MS-based_proteomics_of_urine_in_PD_4_of_5.csv": "3074",
"Project_190_Targeted___untargeted_MS-based_proteomics_of_urine_in_PD_5_of_5.csv": "3075",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Cardiometabolic_panel_counts__CSF_.csv": "2724",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Cardiometabolic_panel_counts__Plasma_.csv": "2731",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Cardiometabolic_panel_normalized_protein_expression__CSF_.csv": "2725",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Cardiometabolic_panel_normalized_protein_expression__Plasma_.csv": "2735",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Inflammation_panel_counts__CSF_.csv": "2727",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Inflammation_panel_counts__Plasma_.csv": "2732",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Inflammation_panel_normalized_protein_expression__CSF_.csv": "2726",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Inflammation_panel_normalized_protein_expression__Plasma_.csv": "2736",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Neurology_panel_counts__CSF_.csv": "2728",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Neurology_panel_counts__Plasma_.csv": "2733",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Neurology_panel_normalized_protein_expression__CSF_.csv": "2739",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Neurology_panel_normalized_protein_expression__Plasma_.csv": "2737",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Oncology_panel_counts__CSF_.csv": "2730",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Oncology_panel_counts__Plasma_.csv": "2734",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Oncology_panel_normalized_protein_expression__CSF_.csv": "2729",
"Project_196_Targeted_Proteomics__Olink_Explore_384_Oncology_panel_normalized_protein_expression__Plasma_.csv": "2738",
"Project_214_O-Link_Measurements_in_Prodromal_PPMI.csv": "3192",
"151_Project_Methods__Identification_of_proteins___protein_networks___pQTL_analysis_in_CSF.csv": "2559",
"196_Project_Methods__Targeted_Proteomics_of_CSF_and_Blood_Plasma_using_Olink_Explore_1536.csv": "3271",
"196_Project_Supporting_Documentation___Targeted_Proteomics_of_CSF_and_Blood_Plasma_using_Olink_Explore_1536.csv": "2740",
"Curated_data_cut_-_Original_Cohort_Baseline_to_Year_5_data.csv": "2203",
"Curated_data_cut_-_Original_Cohort_Baseline_to_Year_5_data_dictionary.csv": "2202",
"Curated_data_cut_-_Prodromal_Cohort_Baseline_to_Year_1_data.csv": "2200",
"Curated_data_cut_-_Prodromal_Cohort_Baseline_to_Year_1_data_dictionary.csv": "2201",
"Variable_Definitions_and_Score_Calculations.csv": "3436",
"Roche_PD_Monitoring_App_v2_data.csv": "2643",
"Roche_PD_Monitoring_App_v2_Methods.csv": "3441",
"Ambulatory_Derived_Data.csv": "2644",
"In_Bed_Times_Derived_Data.csv": "2645",
"On_Wrist_Derived_Data.csv": "2646",
"Pulse_Rate_Derived_Data.csv": "2648",
"Pulse_Rate_Variability_Derived_Data.csv": "2647",
"Sleep_Metrics_Derived_Data.csv": "2649",
"Sleep_Stage_Derived_Data.csv": "2650",
"Step_Count_Derived_Data.csv": "2651",
"Time_Zone_Derived_Data.csv": "2652",
"Verily_Derived_Data_Quick_Start_Guide_PDF_.csv": "2792",
"Verily_Derived_Metrics_for_the_Study_Watch_Methods.csv": "2790",
"Verily_Raw_Device_Data_Request_Form.csv": "2791",
"_Gait_Substudy__Documentation_of_Informed_Consent.csv": "3374",
"_Gait_Substudy__Inclusion_Exclusion_Criteria.csv": "3378",
"_Tau_Substudy__Documentation_of_Informed_Consent.csv": "2567",
"_Tau_Substudy__Eligibility.csv": "2568",
"Conclusion_of_Study_Participation.csv": "2633",
"Continuing_Consent.csv": "2478",
"Documentation_of_Informed_Consent.csv": "2634",
"Documentation_of_Screening_DaTscan_Imaging_Consent.csv": "2492",
"Early_Imaging_Documentation_of_Informed_Consent.csv": "2474",
"Early_Imaging_Eligibility.csv": "2654",
"Early_Imaging_Screen_Fail.csv": "2493",
"Eligibility_Override.csv": "3329",
"FOUND_Enrollment_Status.csv": "1499",
"Inclusion_Exclusion.csv": "2696",
"Informed_Consent_Tracking_Log.csv": "2548",
"MRI_Waiver.csv": "3364",
"Participation_in_Other_Studies_Log.csv": "3032",
"Program_Assessment.csv": "3386",
"Research_Proxy_Designation.csv": "2641",
"Screen_Fail.csv": "2642",
"DaTScan_Analysis.csv": "2580",
"DaTscan_Imaging.csv": "2700",
"DaTScan_Metadata.csv": "2582",
"DaTscan_SPECT_Image_Processing_SBR_Calculation_Methods.csv": "504",
"DaTSCAN_SPECT_Visual_Interpretation_Assessment_Methods.csv": "3433",
"DaTScan_Visual_Interpretation_Results.csv": "2579",
"DTI_Preprocessing_Manual.csv": "242",
"DTI_Regions_of_Interest.csv": "1258",
"DTI_Regions_of_Interest_Methods.csv": "1292",
"Grey_Matter_volume_extraction_from_MRI_T1.csv": "2073",
"Magnetic_Resonance_Imaging__MRI_.csv": "2655",
"MRI_Metadata.csv": "2583",
"rs-fMRI_Data_Availability_and_Usage.csv": "2123",
"_Tau_Substudy__MK-6240_PET_Imaging.csv": "2569",
"AV-133_PET_Analysis.csv": "2578",
"AV-133_PET_Image_Processing_Methods_for_Calculation_of_SBR.csv": "733",
"AV-133_PET_Imaging_Technical_Operations_Manual.csv": "3435",
"AV-133_PET_Metadata.csv": "2581",
"Early_Imaging_AV-133_Imaging.csv": "2694",
"TAU_PET_Analysis.csv": "3144",
"TAU_PET_Metadata.csv": "3143",
"_Gait_Substudy__Adverse_Event_In-Clinic_Assessment.csv": "3372",
"_Gait_Substudy__Adverse_Event_Telephone_Assessment.csv": "3382",
"_Tau_Substudy__Adverse_Event_Telephone_Assessment.csv": "2572",
"_Tau_Substudy__Pregnancy_Test.csv": "2570",
"_Tau_Substudy__Report_of_Pregnancy.csv": "2571",
"Adverse_Event_In-Clinic_Assessment.csv": "3333",
"Adverse_Event_Telephone_Assessment.csv": "2656",
"Clinical_Diagnosis.csv": "3429",
"Clinical_Global_Impression__CGI__-_Investigator.csv": "3366",
"Concomitant_Medication_Log.csv": "2701",
"Determination_of_Freezing_and_Falls.csv": "2467",
"Early_Imaging_Adverse_Event_Telephone_Assessment.csv": "2475",
"Early_Imaging_ECG.csv": "2590",
"Early_Imaging_Pregnancy_Test.csv": "2653",
"Early_Imaging_Report_of_Pregnancy.csv": "2494",
"Early_Imaging_Substudy_Adverse_Event_In-Clinic_Assessment.csv": "3335",
"Features_of_Parkinsonism.csv": "2636",
"General_Physical_Exam.csv": "2637",
"Initiation_of_Dopaminergic_Therapy.csv": "3368",
"LEDD_Concomitant_Medication_Log.csv": "2481",
"Medical_Conditions_Log.csv": "2699",
"Other_Clinical_Features.csv": "2638",
"Participant_Global_Impression__PGI_.csv": "3384",
"PD_Diagnosis_History.csv": "2588",
"Pregnancy_Test.csv": "2640",
"Primary_Clinical_Diagnosis.csv": "2574",
"Prodromal_History.csv": "2697",
"Report_of_Pregnancy.csv": "2471",
"Surgery_for_PD_Log.csv": "2707",
"Vital_Signs.csv": "2491",
"Neurological_Exam.csv": "2639",
"Adverse_Event_Log.csv": "2706",
"Gait_Data___Arm_swing.csv": "1249",
"Gait_Data___Arm_Swing_Methods.csv": "1566",
"MDS-UPDRS_Part_I_Patient_Questionnaire__Non-Motor_Aspects_of_Experiences_of_Daily_Living__nM-EDL_.csv": "2489",
"MDS-UPDRS_Part_I__Non-Motor_Aspects_of_Experiences_of_Daily_Living__nM-EDL_.csv": "2488",
"MDS-UPDRS_Part_II_Patient_Questionnaire__Motor_Aspects_of_Experiences_of_Daily_Living__M-EDL_.csv": "2490",
"MDS-UPDRS_Part_III_Treatment_Determination_and_Part_III__Motor_Examination.csv": "3327",
"MDS-UPDRS_Part_IV__Motor_Complications.csv": "2577",
"Modified_Schwab___England_Activities_of_Daily_Living.csv": "2483",
"Neuro_QoL__Lower_Extremity_Function__Mobility__-_Short_Form.csv": "2486",
"Neuro_QoL__Upper_Extremity_Function__Fine_Motor__ADL__-_Short_Form.csv": "2487",
"Participant_Motor_Function_Questionnaire.csv": "2473",
"SCOPA-AUT.csv": "2470",
"Clock_Drawing.csv": "2711",
"Cognitive_Categorization.csv": "2708",
"Cognitive_Change.csv": "2477",
"Modified_Boston_Naming_Test.csv": "2710",
"Neuro_QoL__Cognition_Function_-_Short_Form.csv": "2484",
"Neuro_QoL__Communication_-_Short_Form.csv": "2485",
"Trail_Making_A_and_B.csv": "2468",
"Geriatric_Depression_Scale__Short_Version_.csv": "2480",
"Questionnaire_for_Impulsive-Compulsive_Disorders_in_Parkinson_s_Disease__QUIP-Current-Short_.csv": "2575",
"State-Trait_Anxiety_Inventory.csv": "2469",
"Benton_Judgement_of_Line_Orientation.csv": "2713",
"Hopkins_Verbal_Learning_Test_-_Revised.csv": "2709",
"Letter_-_Number_Sequencing.csv": "2714",
"Lexical_Fluency.csv": "2482",
"Modified_Semantic_Fluency.csv": "2705",
"Montreal_Cognitive_Assessment__MoCA_.csv": "2712",
"Symbol_Digit_Modalities_Test.csv": "2715",
"University_of_Pennsylvania_Smell_Identification_Test__UPSIT_.csv": "2793",
"Epworth_Sleepiness_Scale.csv": "2479",
"REM_Sleep_Behavior_Disorder_Questionnaire.csv": "2472",
"FOUND_Brief_Summary.csv": "1630",
"FOUND_RFQ_Alcohol.csv": "1600",
"FOUND_RFQ_Anti-Inflammatory_Medications.csv": "1601",
"FOUND_RFQ_Caffeine.csv": "1602",
"FOUND_RFQ_Calcium_Channel_Blockers.csv": "1607",
"FOUND_RFQ_Dictionary.csv": "1557",
"FOUND_RFQ_Female_Reproductive_Health.csv": "1608",
"FOUND_RFQ_Head_Injury.csv": "1609",
"FOUND_RFQ_Height___Weight.csv": "1610",
"FOUND_RFQ_Occupation.csv": "1611",
"FOUND_RFQ_Pesticides_at_Work.csv": "1612",
"FOUND_RFQ_Pesticides_Non-Work.csv": "1613",
"FOUND_RFQ_Physical_Activity.csv": "1614",
"FOUND_RFQ_Residential_History.csv": "1615",
"FOUND_RFQ_Smoking_History.csv": "1616",
"FOUND_RFQ_Toxicant_History.csv": "1617",
"FOUND_Self-Reported_Dx.csv": "2966",
"Cognitive_Change__Online_.csv": "2865",
"PPMI_Online_Codebook.csv": "2870",
"PPMI_Online_Dictionary.csv": "2869",
"Family_History_of_Parkinson_s_Disease_1st_Degree_Relatives__Online_.csv": "2844",
"Assessment_of_Constipation__Online_.csv": "2838",
"Caffeine_Consumption__Online_.csv": "3110",
"Chemical_Exposure__Online_.csv": "3203",
"COVID-19_History__Online_.csv": "2839",
"Head_Injuries__Online_.csv": "3111",
"Health_History_Annually__Online_.csv": "2846",
"Health_History_Quarterly__Online_.csv": "2847",
"History_of_Falls_Baseline__Online_.csv": "2842",
"History_of_Falls_Surveillance__Online_.csv": "2843",
"Medication_History__Online_.csv": "2851",
"Pesticides_at_Work__Online_.csv": "3204",
"Physical_Activity__Online_.csv": "3201",
"Smoking_History__Online_.csv": "2863",
"MDS-UPDRS_Part_I_Non-Motor_Aspects__Online_.csv": "2852",
"MDS-UPDRS_Part_II_Motor_Aspects__Online_.csv": "2866",
"Participant_Motor_Function_Questionnaire__Online_.csv": "2856",
"Geriatric_Depression_Scale__Online_.csv": "2845",
"Parkinson_Anxiety_Scale__Online_.csv": "2868",
"Penn_Parkinson_s_Daily_Activities_Questionnaire-15__Online_.csv": "2854",
"Age_of_Parkinson_s_Disease_Diagnosis__Online_.csv": "2853",
"Genetic_Testing_Results__Online_.csv": "3400",
"High_Interest_Questions_for_Non-PD_Cohort__Online_.csv": "2848",
"High_Interest_Questions_for_PD_Cohort__Online_.csv": "2849",
"Hyposmia_1Qx_from_Remote__Online_.csv": "2850",
"Parkinson_s_Disease_History_Return_Study_Visit_for_NonPD_Cohort__Online_.csv": "2859",
"Parkinson_s_Disease_History_Return_Study_Visit_for_PD_Cohort__Online_.csv": "2860",
"Participant-Visit_Information__Online_.csv": "2864",
"Epworth_Sleepiness_Scale__Online_.csv": "2840",
"Parkinson_s_Disease_Sleep_Scale_PDSS-2__Online_.csv": "2855",
"PPMI_RBD_Sleep_Questionnaire__Online_.csv": "2858",
"RBD1Q_Postuma_Acting_out_Dreams__Online_.csv": "2857",
"How_you_heard_about_PPMI__Online_.csv": "3202",
"Non-Completer_Survey__Online_.csv": "3205",
"Participant_Enrollment_Status__Online_.csv": "2867",
"Occupation_and_Military_Service__Online_.csv": "3402",
"Race_and_Ethnicity__Online_.csv": "2841",
"Registration_Information__Online_.csv": "2861",
"Residential_Location__Online_.csv": "3401",
"Socioeconomic_Status__Online_.csv": "2862",
"Remote_Screening_High_Interest_Questionnaire.csv": "3274",
"Remote_Screening_Participant_Progress.csv": "3278",
"Remote_Screening_Screener.csv": "3272",
"Remote_Screening_Smell_Test_Direct_Screener.csv": "3275",
"Remote_Screening_UPSIT_Screening_Questionnaire.csv": "3276",
"1_0_Study_CRFs_and_Assessments.csv": "1565",
"101_Project_Methods__2011_Pilot_CSF_a-beta__tau__and_p-tau_measurements.csv": "223",
"102_Project_Methods__Hemoglobin_Biospecimen_Analysis.csv": "222",
"103_Project_Methods__2011_Pilot_CSF_aSyn_measurements.csv": "263",
"110_Project_Methods__CSF_Biospecimen_Analysis.csv": "742",
"111_Project_Methods__Alpha-synuclein_Assay.csv": "743",
"138_Project_Methods__Hemoglobin_Biospecimen_Analysis.csv": "1538",
"Methods_for_Defining_PD_Med_Use.csv": "1232",
"Olfactory_UPSIT_Methods.csv": "1341",
"PPMI_CSF_Assay_Variability_April_2014.csv": "731",
"Prodromal_Diagnostic_Code_Memo.csv": "1821",
"Symptomatic_Therapy_Visits_Method.csv": "1230",
"2022-0001_Serrano-Fernandez__Parkinson_s_Disease_Proteogenomics.csv": "3137"
}